NanoString to Host Virtual Investor and Analyst Day on December 1st, 2020
The event will include:
- An updated view of the total addressable market for spatial biology
- An overview of the adoption of the GeoMx® Digital Spatial Profiler
- A review of the company’s technology roadmap for spatial biology
The presentations will be followed by a Q&A session with management.
The presentations and accompanying slides will be webcast live on the company's website at https://investors.nanostring.com/events-webcasts. The webcast will be available on the company site for 90 days.
About NanoString Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 3,800 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
For more information, please visit www.nanostring.com.
NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
Vice President, Investor Relations & Corporate Communications
Source: NanoString Technologies, Inc.